Over-activation of the RAS plays an essential role in the pathogenesis of hypertension as evidenced by the wide use of angiotensin-converting enzyme (ACE) inhibitors and AT1-receptor antagonists for the management of human hypertension [1–3]. The gene discussed is ACE; the disease is Hypertension.